RVL Pharmaceuticals plc carries a market capitalization of 110.18M, placing it among publicly traded companies globally.
| Market Cap | 110.18M |
| Enterprise Value | N/A |
RVL Pharmaceuticals plc's stock has declined approximately -11.90476% over the past 52 weeks. The 50-day moving average sits at 1.15, while the 200-day moving average is 2.48.
| Beta (5Y) | N/A |
| 52-Week Price Change | -11.90476% |
| 50-Day Moving Average | 1.15 |
| 200-Day Moving Average | 2.48 |
| Average Volume (20 Days) | N/A |